KR100638709B1 - Ｎ－치환된－ 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물 - Google Patents

Ｎ－치환된－ 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물 Download PDF

Info

Publication number
KR100638709B1
KR100638709B1 KR1020040059038A KR20040059038A KR100638709B1 KR 100638709 B1 KR100638709 B1 KR 100638709B1 KR 1020040059038 A KR1020040059038 A KR 1020040059038A KR 20040059038 A KR20040059038 A KR 20040059038A KR 100638709 B1 KR100638709 B1 KR 100638709B1
Authority
KR
South Korea
Prior art keywords
group
morpholino
formula
phenyl
substituted
Prior art date
Application number
KR1020040059038A
Other languages
English (en)
Korean (ko)
Other versions
KR20060010370A (ko
Inventor
김종우
이상욱
이근형
한재진
박상진
박을용
신중철
Original Assignee
(주) 비엔씨바이오팜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 비엔씨바이오팜 filed Critical (주) 비엔씨바이오팜
Priority to KR1020040059038A priority Critical patent/KR100638709B1/ko
Priority to PCT/KR2005/002257 priority patent/WO2006011719A1/fr
Publication of KR20060010370A publication Critical patent/KR20060010370A/ko
Application granted granted Critical
Publication of KR100638709B1 publication Critical patent/KR100638709B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020040059038A 2004-07-28 2004-07-28 Ｎ－치환된－ 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물 KR100638709B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020040059038A KR100638709B1 (ko) 2004-07-28 2004-07-28 Ｎ－치환된－ 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물
PCT/KR2005/002257 WO2006011719A1 (fr) 2004-07-28 2005-07-13 Derives d'acide sulfamoylbenzoique n-substitue, leur procede de preparation et composition pharmaceutique antivirale les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040059038A KR100638709B1 (ko) 2004-07-28 2004-07-28 Ｎ－치환된－ 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물

Publications (2)

Publication Number Publication Date
KR20060010370A KR20060010370A (ko) 2006-02-02
KR100638709B1 true KR100638709B1 (ko) 2006-10-25

Family

ID=35786434

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040059038A KR100638709B1 (ko) 2004-07-28 2004-07-28 Ｎ－치환된－ 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물

Country Status (2)

Country Link
KR (1) KR100638709B1 (fr)
WO (1) WO2006011719A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE548044T1 (de) 2007-05-04 2012-03-15 Vertex Pharma Kombinationstherapie zur behandlung von hiv- infektionen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0515128A1 (fr) * 1991-05-23 1992-11-25 Konica Corporation Matériau à l'halogénure d'argent pour photographie en couleurs
US20050113450A1 (en) * 2002-08-23 2005-05-26 Atli Thorarensen Antibacterial agents

Also Published As

Publication number Publication date
WO2006011719A1 (fr) 2006-02-02
KR20060010370A (ko) 2006-02-02

Similar Documents

Publication Publication Date Title
KR100700676B1 (ko) 6―（4―치환된―아닐리노）피리미딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
KR100516434B1 (ko) 6-(4-치환된-아닐리노)피리미딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
KR100490893B1 (ko) 2-메톡시-1,3,5-트리아진 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
KR100516432B1 (ko) 2-(4-치환된-아닐리노)피리딘 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물
KR100638709B1 (ko) Ｎ－치환된－ 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물
KR100502394B1 (ko) 2-[2-(4-모르포리노)에틸아미노]피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
KR100490892B1 (ko) 4-(4-치환된-아닐리노)피리미딘 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물
KR100453946B1 (ko) 6-메틸피리딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
KR100502395B1 (ko) 4-[4-(4-모르포리노)아닐리노]피리미딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물.
KR100516433B1 (ko) 2-(2-치환된-아닐리노)피리딘 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물
KR100469085B1 (ko) 3,4,5-트리플루오로피리딘 유도체, 그의 제조방법 및 이를포함하는 항바이러스용 약학적 조성물
KR100446669B1 (ko) 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
KR100457857B1 (ko) 2-[2-(3-인돌릴)에틸아미노]피리딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
KR100661081B1 (ko) 항바이러스제로 유용한 6-메틸니코틴아미드 유도체
KR20080061613A (ko) 2-(메틸티오)피리미딘 유도체, 그 제조방법 및 이를포함하는 항바이러스용 약학적 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee